JPS6323820B2 - - Google Patents
Info
- Publication number
- JPS6323820B2 JPS6323820B2 JP56008996A JP899681A JPS6323820B2 JP S6323820 B2 JPS6323820 B2 JP S6323820B2 JP 56008996 A JP56008996 A JP 56008996A JP 899681 A JP899681 A JP 899681A JP S6323820 B2 JPS6323820 B2 JP S6323820B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- tablets
- valine
- tablet composition
- lubricant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 22
- 239000007916 tablet composition Substances 0.000 claims description 13
- 229960004295 valine Drugs 0.000 claims description 11
- 239000000314 lubricant Substances 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000004604 Blowing Agent Substances 0.000 claims description 2
- 239000007884 disintegrant Substances 0.000 claims description 2
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 28
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 239000002994 raw material Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000007908 dry granulation Methods 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000009702 powder compression Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000004554 water soluble tablet Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
Description
本発明は錠剤組成物に関し、詳しくは錠剤製造
時の滑沢効果がすぐれた錠剤組成物に関する。
現在では医薬品、食品、食品添加物などの種々
の製品における形態として錠剤は主要な位置を占
めている。この錠剤については、その使用目的に
応じて崩壊性、分散性、溶解性、発泡性などの性
質のうちの1乃至全部を満足することが要求さ
れ、そのために主剤と配合する添加剤として崩壊
剤、分散剤、発泡剤等について種々の検討がなさ
れている。さらに、錠剤製造時の立場から賦形
剤、結合剤、滑沢剤などの添加剤についても各種
の物質が開発されている。
ところで、錠剤製造に際して滑沢剤の選定がき
わめて重要である。これまでに滑沢剤としてステ
アリン酸マグネシウム、ステアリン酸カリシウ
ム、タルク、デンプン、L−ロイシン、イソロイ
シンなどが知られているが、これらのうちのある
ものは添加量の制約があつて十分な効果が発揮さ
れなかつたり、またあるものは異臭を与え、さら
にあるものは水溶性錠剤に不適当であつたり、食
品添加物として許容できない等の不都合があり、
いずれも十分に満足し得るものではなかつた。
このような事情に鑑み、本発明者らは滑沢効果
にすぐれるとともに水溶性であること、食品添加
物として許容されること、白色であること、官能
に悪影響を及ぼさないこと等の条件を満足する滑
沢剤を開発すべく鋭意研究を重ねた結果、必須ア
ミノ酸の1つであるL−バリンがこの目的に適合
することを見出し、本発明を完成するに至つた。
本発明は主剤と添加剤からなる配合物に滑沢剤
としてL−バリンを加えたことを特徴とする錠剤
組成物に関するものである。
本発明において主剤としては各種のものがあ
り、たとえば薬剤、食品、嗜好品、甘味料などを
挙げることができる。同様に添加剤についても各
種のものがあり、主剤との関係や錠剤製造法など
を考慮して適宜選択されるが、たとえば小麦でん
ぷん、バレイシヨでんぷん、コーンスターチなど
のでんぷん類、ブドウ糖、シヨ糖、乳糖、ソルビ
ツトなどの糖類、リン酸カルシウム、硫酸カルシ
ウムなどの無機物質等の賦形剤(または希釈
剤);でんぷん、シヨ糖、ゼラチン、アラビアゴ
ム、メチルセルロース等の結合剤;でんぷん、で
んぷん誘導体、セルロース、セルロース誘導体等
の崩壊剤;炭酸水素ナトリウム等の発泡剤などが
ある。さらに、必要に応じて前記した既知の滑沢
剤を使用することもできる。
滑択剤として用いるL−バリンの添加量につい
ては錠剤の所望硬度を考慮して決定すべきであ
り、通常は2〜10%程度である。比較的低硬度の
錠剤を得たい場合は、L−バリンを5%以上、好
ましくは5〜8%加えればよい。特に主剤として
甘味料、たとえばα−L−アスパルチル−L−フ
エニルアラニン・メチルエステル(以下、APと
略す。)で代表されるジペプチド甘味料を用いる
場合は、錠剤は速溶解性であることが必要であ
り、このような要求に応えるためにはL−バリン
の添加量を約6%程度として低硬度の錠剤を得る
ことができる。
本発明の錠剤組成物より錠剤を製造する場合、
直接粉末圧縮法、湿式造粒法および乾式造粒法の
いずれの方法も適用できる。湿式造粒法による錠
剤の製造工程を示すと、各原料を適量づゝ配合し
た錠剤組成物ならびに必要に応じて水、有機溶
媒、シロツプまたはこれらの混液などを加えて得
た湿潤物を混合、〓和した後、造粒する。乾式造
粒法においては各原料配合物をスラツグ打錠し、
粉砕、篩分けして造粒する。これらの操作により
得られた顆粒品を本打錠し製品を得る。なお、直
接粉末圧縮法は配合した原料を強制フイーダーに
より直接打錠するものである。
本発明の錠剤組成物は滑択剤としてL−バリン
を使用しているため、特に主剤として甘味料を用
い速溶解性の錠剤の製造が望まれる場合に、適し
ており、良好な打錠性を示して所望の錠剤を得る
ことができる。
次に、本発明の実施例を示す。
実施例 1
下表の組成の錠剤組成物を用い乾式造粒法によ
つて錠剤を製造した。
The present invention relates to a tablet composition, and more particularly to a tablet composition with excellent lubricating effect during tablet production. At present, tablets occupy a major position as a form of various products such as pharmaceuticals, foods, and food additives. These tablets are required to satisfy one or all of the following properties, such as disintegration, dispersibility, solubility, and effervescence, depending on the purpose of use. , dispersants, foaming agents, etc., have been studied in various ways. Furthermore, various substances have been developed for additives such as excipients, binders, and lubricants from the standpoint of tablet manufacturing. Incidentally, the selection of a lubricant is extremely important when manufacturing tablets. So far, magnesium stearate, potassium stearate, talc, starch, L-leucine, isoleucine, etc. have been known as lubricants, but some of these have limited amounts and are not sufficiently effective. Some have inconveniences, such as not being effective, some giving off a strange odor, and some being unsuitable for water-soluble tablets and not being acceptable as food additives.
None of them were fully satisfactory. In view of these circumstances, the present inventors have set conditions such as having excellent lubricity, being water-soluble, being acceptable as a food additive, being white, and having no adverse effect on the senses. As a result of intensive research in order to develop a satisfactory lubricant, it was discovered that L-valine, one of the essential amino acids, is suitable for this purpose, leading to the completion of the present invention. The present invention relates to a tablet composition characterized in that L-valine is added as a lubricant to a blend consisting of a base ingredient and an additive. In the present invention, there are various types of main ingredients, such as drugs, foods, luxury goods, sweeteners, etc. Similarly, there are various types of additives, and they are selected depending on the relationship with the base ingredient and the tablet manufacturing method, but examples include starches such as wheat starch, potato starch, and corn starch, glucose, sucrose, and lactose. Excipients (or diluents) such as sugars such as , sorbitol, and inorganic substances such as calcium phosphate and calcium sulfate; Binders such as starch, sucrose, gelatin, gum arabic, and methylcellulose; Starch, starch derivatives, cellulose, and cellulose derivatives disintegrants such as; blowing agents such as sodium hydrogen carbonate, etc. Furthermore, the above-mentioned known lubricants can also be used if necessary. The amount of L-valine used as a lubricant should be determined in consideration of the desired hardness of the tablet, and is usually about 2 to 10%. If it is desired to obtain tablets with relatively low hardness, L-valine may be added in an amount of 5% or more, preferably 5 to 8%. In particular, when using a sweetener as the main ingredient, such as a dipeptide sweetener represented by α-L-aspartyl-L-phenylalanine methyl ester (hereinafter abbreviated as AP), the tablet should be rapidly dissolvable. In order to meet such demands, tablets with low hardness can be obtained by setting the amount of L-valine added to about 6%. When manufacturing tablets from the tablet composition of the present invention,
Any of the direct powder compression method, wet granulation method and dry granulation method can be applied. The manufacturing process of tablets using the wet granulation method is as follows: A tablet composition containing appropriate amounts of each raw material is mixed with a wet material obtained by adding water, an organic solvent, syrup, or a mixture thereof as necessary. 〓After the mixture is mixed, it is granulated. In the dry granulation method, each raw material mixture is compressed into slug tablets,
Grind, sieve and granulate. The granules obtained by these operations are compressed into a final tablet to obtain a product. In the direct powder compression method, the blended raw materials are directly compressed into tablets using a forced feeder. Since the tablet composition of the present invention uses L-valine as a lubricant, it is suitable especially when a sweetener is used as the main ingredient and it is desired to produce a rapidly dissolving tablet, and it has good tableting properties. The desired tablet can be obtained. Next, examples of the present invention will be shown. Example 1 Tablets were manufactured by dry granulation using the tablet compositions shown in the table below.
【表】
各試料はスラツグ打錠、本打錠ともスムーズに
機械の運転が出来た。なお、各試料による錠剤の
重量、外観ならびに溶解時間を第2表に示す。[Table] The machine could be operated smoothly for both slug tableting and main tableting for each sample. Table 2 shows the weight, appearance, and dissolution time of the tablets for each sample.
【表】
第2表から明らかなように、得られた錠剤はい
ずれも低硬度であり、溶解性にすぐれている。こ
れに対してL−バリン無添加の場合は、錠剤組成
物の摩擦抵抗が多大なため、打錠機においては機
械にきしみ音が発し、同様に本打錠機においては
錠剤がキネに付着してしまい打錠不可能であつ
た。
実施例 2
砂糖(グラニユー糖)85%、デキストリン(商
品名:アミコール7H、日澱化学(株)製)10%およ
びL−バリン5%よりなる錠剤組成物を打錠して
直径20mmの錠剤(錠菓)を得た。この場合の打錠
性は良好で付着もなかつた。
一方、L−バリン無添加のものについては原料
の摩擦抵抗が多大なため、キネへの付着が起り、
したがつて打錠機にきしみ音を発し打錠不可能で
あつた。[Table] As is clear from Table 2, all of the obtained tablets had low hardness and excellent solubility. On the other hand, when L-valine is not added, the frictional resistance of the tablet composition is large, so the tablet machine makes a squeaking sound, and the tablet sticks to the kinematics in the tablet machine as well. It was impossible to press the tablets. Example 2 A tablet composition consisting of 85% sugar (granulated sugar), 10% dextrin (trade name: AMYCOL 7H, manufactured by Nichiden Chemical Co., Ltd.) and 5% L-valine was compressed to form tablets with a diameter of 20 mm ( Tablet confectionery) was obtained. In this case, the tableting properties were good and there was no adhesion. On the other hand, for those without L-valine addition, the frictional resistance of the raw material is great, so it tends to stick to the kinematics.
As a result, the tablet press produced a creaking sound, making it impossible to press the tablets.
Claims (1)
L−バリンを加えたことを特徴とする錠剤組成
物。 2 添加剤が賦形剤、結合剤、崩壊剤、発泡剤お
よび滑沢剤(但し、L−バリンを除く)よりなる
群から選ばれた少なくとも1種の物質である特許
請求の範囲第1項記載の錠剤組成物。 3 主剤がジペプチド甘味料である特許請求の範
囲第1項記載の錠剤組成物。 4 ジペプチド甘味料がα−L−アスパルチル−
L−フエニルアラニン・メチルエステルである特
許請求の範囲第3項記載の錠剤組成物。[Scope of Claims] 1. A tablet composition characterized in that L-valine is added as a lubricant to a blend consisting of a base ingredient and an additive. 2. Claim 1, wherein the additive is at least one substance selected from the group consisting of excipients, binders, disintegrants, blowing agents, and lubricants (excluding L-valine). Tablet compositions as described. 3. The tablet composition according to claim 1, wherein the base ingredient is a dipeptide sweetener. 4 The dipeptide sweetener is α-L-aspartyl-
The tablet composition according to claim 3, which is L-phenylalanine methyl ester.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56008996A JPS57122925A (en) | 1981-01-26 | 1981-01-26 | Tablet composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56008996A JPS57122925A (en) | 1981-01-26 | 1981-01-26 | Tablet composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57122925A JPS57122925A (en) | 1982-07-31 |
JPS6323820B2 true JPS6323820B2 (en) | 1988-05-18 |
Family
ID=11708292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56008996A Granted JPS57122925A (en) | 1981-01-26 | 1981-01-26 | Tablet composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57122925A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60199365A (en) * | 1984-03-22 | 1985-10-08 | Ajinomoto Co Inc | Composition containing amino acid |
FR2600893B1 (en) * | 1986-07-01 | 1990-01-12 | Sandoz Lab | NEW PHARMACEUTICAL COMPOSITIONS BASED ON CALCIUM SALTS |
-
1981
- 1981-01-26 JP JP56008996A patent/JPS57122925A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57122925A (en) | 1982-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU779334B2 (en) | Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants | |
US4013775A (en) | Process for preparing a sugar tablet | |
US20090291179A1 (en) | Method for producing high-protein soybean snack food | |
MXPA02000290A (en) | Rapid immediate release oral dosage form. | |
JP2003292436A (en) | Hard sugar coated preparation, sugar coating solution and method for producing hard sugar coated preparation | |
EP0028905B1 (en) | Tablets containing isomaltulose, their use and a method of producing them | |
WO2005079603A1 (en) | Dietary fiber composition | |
EP0844881B1 (en) | Laxative comprising lactitol and psyllium | |
AU2005315899B9 (en) | Process for making bouillon or seasoning cubes | |
US4520009A (en) | Sustained released aspirin formulation | |
AU2005315984B2 (en) | Process for making bouillon or seasoning cubes | |
AU781205B2 (en) | Directly compressable raw material for tablets | |
KR102571340B1 (en) | Effervescent compositions containing co-crystals of the acid part | |
EP1675865A1 (en) | Process for preparing solidified maltitol and its use in food and pharma products | |
JP4361597B2 (en) | Disintegrant and tablets and granules containing the same | |
JPS6323820B2 (en) | ||
US4670251A (en) | Microcrystalline tableting excipient derived from whey | |
US6455069B1 (en) | Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets | |
CA1201923A (en) | Acesulfam-containing compositions, tablets on the basis thereof and process for the manufacture of these tablets | |
US3961004A (en) | Method of tabletting using gluconolactone as the direct compression diluent | |
JPH07163300A (en) | Production of chewing gum | |
JPH0568214B2 (en) | ||
JPS5832828A (en) | Disintegrating agent | |
JPS5925672A (en) | Soup square or solid seasoning similar to soup | |
JPH0867623A (en) | Composition for taste-correcting oral preparation |